NAMS Stock Analysis: Buy, Sell, or Hold?
NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares
$35.74
-0.01 (-0.03%)
▼
5d:
-3.09%
30d:
+11.9%
90d:
+0.45%
BUY
HIGH Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When NAMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NAMS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: NAMS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: NAMS is currently trading at $35.74, which is considered slightly high relative to its 30-day fair value range of $30.00 to $36.58.
Technical Outlook: Technically, NAMS is showing sideways momentum. Immediate support is located at $32.96, while resistance sits at $42.20.
Market Sentiment: NAMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $50.08 (+40.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NAMS is showing sideways momentum. Immediate support is located at $32.96, while resistance sits at $42.20.
Market Sentiment: NAMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $50.08 (+40.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$30.00 -
$36.58
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.1% below Wall St target ($50.08)
Trading Range Analysis
30-Day Trading Range
$30.00 -
$36.58
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$32.96
Resistance Level
$42.21
Current Trend
Sideways
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-27.09
Wall Street Target
$50.08
(+40.1%)
Revenue Growth (YoY)
-99.8%
Share & Embed Analysis
Last updated: May 21, 2026 5:59 PM ET
Data refreshes hourly during market hours. Next update: 6:59 PM
Data refreshes hourly during market hours. Next update: 6:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Louis G Lange
SELL
44619 shares
2026-03-11
Johannes Jacob Piete Kas…
SELL
101409 shares
2026-03-09
Johannes Jacob Piete Kas…
SELL
94124 shares
2026-03-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 64 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$203 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 52 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 68 BUY |
Advanced NAMS Option Strategies
Professional options setups generated by AI based on today's NAMS price and gamma walls.
